Can Chemed Corporation (CHE)’s Tomorrow be Different? The Stock Formed a Double Top Pattern

June 19, 2017 - By Dolores Ford

Investors sentiment increased to 1.05 in Q4 2016. Its up 0.23, from 0.82 in 2016Q3. It increased, as 19 investors sold Chemed Corporation shares while 81 reduced holdings. 31 funds opened positions while 74 raised stakes. 16.12 million shares or 3.72% more from 15.54 million shares in 2016Q3 were reported.
Teacher Retirement Of Texas reported 1,303 shares. Shell Asset Mngmt Co has invested 0.07% in Chemed Corporation (NYSE:CHE). Gemmer Asset Management Ltd Limited Liability Company reported 0% stake. Prudential Financial reported 0.01% in Chemed Corporation (NYSE:CHE). Blackrock Institutional Tru Na holds 0.01% of its portfolio in Chemed Corporation (NYSE:CHE) for 428,866 shares. Jefferies Grp Limited Liability Company owns 0% invested in Chemed Corporation (NYSE:CHE) for 3,269 shares. Parametric Associates Lc has 57,186 shares for 0.01% of their portfolio. Citigroup Inc stated it has 24,530 shares or 0% of all its holdings. Swiss Comml Bank owns 26,600 shares or 0.01% of their US portfolio. 15,000 were reported by Sivik. Qs Limited Liability Corporation owns 1,062 shares for 0% of their portfolio. Alps Advsr accumulated 0% or 2,943 shares. Hsbc Hldg Public Ltd holds 0% in Chemed Corporation (NYSE:CHE) or 3,569 shares. Royal State Bank Of Canada invested in 0% or 7,033 shares. Fuller & Thaler Asset Mngmt reported 400 shares.

Since February 23, 2017, it had 1 buying transaction, and 5 insider sales for $3.81 million activity. On Thursday, February 23 MCNAMARA KEVIN J sold $1.24M worth of Chemed Corporation (NYSE:CHE) or 7,000 shares. Shares for $2,943 were bought by WALSH GEORGE J III on Friday, March 31. TUCKER ARTHUR V JR had sold 2,266 shares worth $410,146. $62,615 worth of Chemed Corporation (NYSE:CHE) shares were sold by SAUNDERS DONALD E.

The chart of Chemed Corporation (CHE) shows a double top with $222.53 target or 8.00 % above today’s $206.05 share price. The 7 months chart pattern indicates low risk for the $3.31 billion company. It was reported on Jun, 19 by If the $222.53 price target is reached, the company will be worth $264.80 million more. Double tops are rare but powerful chart patterns.

About 725 shares traded. Chemed Corporation (NYSE:CHE) has risen 54.48% since June 19, 2016 and is uptrending. It has outperformed by 37.78% the S&P500.

Analysts await Chemed Corporation (NYSE:CHE) to report earnings on July, 24. They expect $1.88 EPS, up 9.94 % or $0.17 from last year’s $1.71 per share. CHE’s profit will be $30.20M for 27.40 P/E if the $1.88 EPS becomes a reality. After $1.82 actual EPS reported by Chemed Corporation for the previous quarter, Wall Street now forecasts 3.30 % EPS growth.

Chemed Corporation (NYSE:CHE) Ratings Coverage

Among 2 analysts covering Chemed (NYSE:CHE), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Chemed had 8 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Chemed Corporation (NYSE:CHE) has “Outperform” rating given on Monday, October 26 by Oppenheimer. The firm has “Hold” rating by RBC Capital Markets given on Tuesday, May 30. The firm has “Sector Perform” rating by RBC Capital Markets given on Monday, July 27. Oppenheimer maintained Chemed Corporation (NYSE:CHE) rating on Tuesday, September 22. Oppenheimer has “Outperform” rating and $150.0 target. RBC Capital Markets maintained it with “Sector Perform” rating and $154 target in Monday, October 26 report. RBC Capital Markets maintained Chemed Corporation (NYSE:CHE) rating on Tuesday, November 1. RBC Capital Markets has “Sector Perform” rating and $148 target. The firm has “Sector Perform” rating by RBC Capital Markets given on Monday, May 2.

More notable recent Chemed Corporation (NYSE:CHE) news were published by: which released: “206.62” on December 21, 2009, also with their article: “Chemed Corp. CHE (US: NYSE)” published on February 11, 2011, published: “Chemed: Hospice And…Plumbing?” on April 04, 2017. More interesting news about Chemed Corporation (NYSE:CHE) were released by: and their article: “Chemed Corporation to Present at the Bank of America Merrill Lynch 2017 Health …” published on May 11, 2017 as well as‘s news article titled: “A Value Investor’s Dream: Chemed Corporation” with publication date: November 05, 2013.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.